Cargando…

Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma

Neuroblastoma (NB) and malignant melanoma (MM), tumors of pediatric age and adulthood, respectively, share a common origin, both of them deriving from the neural crest cells. Although NB and MM have a different behavior, in respect to age of onset, primary tissue involvement and metastatic spread, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morandi, Fabio, Frassoni, Francesco, Ponzoni, Mirco, Brignole, Chiara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232800/ https://www.ncbi.nlm.nih.gov/pubmed/30510968 http://dx.doi.org/10.1155/2018/8097398

Ejemplares similares

Immunotherapeutic Strategies for Neuroblastoma: Present, Past and Future
por: Morandi, Fabio, et al.
Publicado: (2021)

The Olive Leaves Extract Has Anti-Tumor Effects against Neuroblastoma through Inhibition of Cell Proliferation and Induction of Apoptosis
por: Morandi, Fabio, et al.
Publicado: (2021)

Bone Marrow Environment in Metastatic Neuroblastoma
por: Brignole, Chiara, et al.
Publicado: (2021)

Recent advances in the developmental origin of neuroblastoma: an overview
por: Ponzoni, Mirco, et al.
Publicado: (2022)

Nanocarrier-Mediated Targeting of Tumor and Tumor Vascular Cells Improves Uptake and Penetration of Drugs into Neuroblastoma
por: Pastorino, Fabio, et al.
Publicado: (2013)

Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer
por: Ponzoni, Mirco, et al.
Publicado: (2018)

A Review of Immunotherapeutic Strategies in Canine Malignant Melanoma
por: Almela, Ramón M., et al.
Publicado: (2019)

Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
por: Brignole, Chiara, et al.
Publicado: (2021)

Immunotherapeutic Approaches in Malignant Pleural Mesothelioma
por: Terenziani, Rita, et al.
Publicado: (2021)

Current Immunotherapeutic Approaches for Malignant Gliomas
por: Han, Myung-Hoon, et al.
Publicado: (2022)

New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK
por: Di Paolo, Daniela, et al.
Publicado: (2015)

CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
por: Morandi, Fabio, et al.
Publicado: (2018)

Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma
por: Brignole, Chiara, et al.
Publicado: (2023)

Retinoids Delivery Systems in Cancer: Liposomal Fenretinide for Neuroectodermal-Derived Tumors
por: Bensa, Veronica, et al.
Publicado: (2021)

Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
por: Wolchok, Jedd D, et al.
Publicado: (2013)

Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches
por: Bottino, Cristina, et al.
Publicado: (2014)

Peptide Vaccines in Melanoma: Chemical Approaches towards Improved Immunotherapeutic Efficacy
por: Biri-Kovács, Beáta, et al.
Publicado: (2023)

Immunotherapeutic advances in gastrointestinal malignancies
por: Rao, Devika, et al.
Publicado: (2019)

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
por: Lee, Eunjin, et al.
Publicado: (2020)

Nucleolin expression has prognostic value in neuroblastoma patients
por: Cangelosi, Davide, et al.
Publicado: (2022)

Refining immunotherapeutic approaches to high‐risk neuroblastoma based on tumor genomic profiles
por: Grossmann, Liron D., et al.
Publicado: (2020)

Molecular Determinants of Neuroblastoma
por: Morandi, Fabio
Publicado: (2022)

Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric Oncology
por: Pastorino, Fabio, et al.
Publicado: (2023)

Vaccines and Immunotherapeutics for the Treatment of Malignant Disease
por: Aldrich, Joel F., et al.
Publicado: (2010)

Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells
por: Pisano, Marina, et al.
Publicado: (2010)

A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma
por: Perri, Patrizia, et al.
Publicado: (2021)

The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma
por: Rango, Enrico, et al.
Publicado: (2022)

The Role of Extracellular Vesicles in the Progression of Human Neuroblastoma
por: Marimpietri, Danilo, et al.
Publicado: (2021)

CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma
por: Sussman, Robyn T., et al.
Publicado: (2020)

Immunotherapeutic approaches for hepatocellular carcinoma
por: Longo, Vito, et al.
Publicado: (2017)

Immunotherapeutic Approaches for Glioblastoma Treatment
por: Yaghi, Nasser K., et al.
Publicado: (2022)

Immunotherapeutic Approaches in Ovarian Cancer
por: Yoon, Hyunho, et al.
Publicado: (2023)

PHOX2B-Mediated Regulation of ALK Expression: In Vitro Identification of a Functional Relationship between Two Genes Involved in Neuroblastoma
por: Bachetti, Tiziana, et al.
Publicado: (2010)

Novel Immunotherapeutic Strategies of Gastric Cancer Treatment
por: Amedei, Amedeo, et al.
Publicado: (2011)

Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma
por: Bann, Darrin V., et al.
Publicado: (2016)

New Immunotherapeutic Approaches for Glioblastoma
por: Vázquez Cervantes, Gustavo Ignacio, et al.
Publicado: (2021)

Mechanisms of action underlying the immunotherapeutic activity of Allovectin in advanced melanoma
por: Doukas, J, et al.
Publicado: (2012)

The Immunotherapeutic Role of Type I and III Interferons in Melanoma and Non-Melanoma Skin Cancers
por: Weir, Sydney A., et al.
Publicado: (2023)

Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas
por: Cantilena, Sandra, et al.
Publicado: (2011)

Antibody-Based Immunotherapeutic Strategies for the Treatment of Hematological Malignancies
por: Han, Yizhao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e7d5a3f5fvdbmoccc7o3cu95ub